Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00603Delavirdine--
BADD_D00604Delavirdine mesylate--
BADD_D00608Denosumab--
BADD_D00609Deoxycholic acid--
BADD_D00623Dexamethasone0.001337%
BADD_D00628Dexlansoprazole--
BADD_D00648Diazepam--
BADD_D00653Diclofenac--
BADD_D00661Didanosine--
BADD_D00680Dimethyl fumarate--
BADD_D00685Dinutuximab--
BADD_D00693Disopyramide--
BADD_D00704Dolutegravir sodium0.001242%
BADD_D00706Donepezil0.000141%
BADD_D00707Donepezil hydrochloride--
BADD_D00722Doxercalciferol--
BADD_D00723Doxorubicin--
BADD_D00725Doxycycline--
BADD_D00734Duloxetine--
BADD_D00735Duloxetine hydrochloride--
BADD_D00736Dutasteride--
BADD_D00749Efavirenz0.023489%
BADD_D00765Empagliflozin--
BADD_D00766Emtricitabine--
BADD_D00771Enfuvirtide--
BADD_D00773Entacapone--
BADD_D00774Entecavir--
BADD_D00786Eplerenone--
BADD_D00790Eprosartan--
BADD_D00791Eprosartan mesylate--
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target